Company Search:
Advanced Search
Sponsored Links
Galmed Pharmaceuticals Ltd Company Snapshot
Galmed Pharmaceuticals Ltd operates in the Commercial physical research sector. In addition to historical fundamental analyses, the complete report available to purchase compares Galmed Pharmaceuticals Ltd with three other companies in this sector in the United States: Ocular Therapeutix Inc (2018 sales of $1.99 million of which 100% was Biopharmaceutical Preparations), Eyegate Pharmaceuticals Inc ($1.65 million of which 100% was Eyecare products), and Crinetics Pharmaceuticals Inc ($2.43 million of which 100% was Pharmaceutical Preparations).

Sales Analysis.
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
Galmed Pharmaceuticals Ltd
  Stock Performance Chart for Galmed Pharmaceuticals Ltd
  Stock Data: Recent Stock Performance:
  Current Price (12/13/2019): 6.06
(Figures in U.S. Dollars)
1 Week -6.8%   13 Weeks 38.7%  
4 Weeks 15.9%   52 Weeks -27.1%  
Galmed Pharmaceuticals Ltd Key Data:
  Ticker: GLMD Country: Israel
  Exchanges: NAS Major Industry: Commercial Services & Supplies
    Sub Industry: Commercial Physical Research
  2018 Sales 2,038,000
(Year Ending Jan 2019).
Employees: 21
  Currency: U.S. Dollars Market Cap: 128,012,107
  Fiscal Yr Ends: December Shares Outstanding: 21,124,110
  Share Type: Common Closely Held Shares: 4,483,361
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.